{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:20:44Z","timestamp":1783480844805,"version":"3.55.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.mayocp.2015.05.002","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T01:48:22Z","timestamp":1437184102000},"page":"1247-1261","source":"Crossref","is-referenced-by-count":26,"title":["Volume Overload in Heart Failure"],"prefix":"10.1016","volume":"90","author":[{"given":"Brian A.","family":"Houston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan J.","family":"Kalathiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocp.2015.05.002_bib1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Failure"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MNH.0b013e3282f357da","article-title":"Renal hemodynamics in heart failure: implications for treatment","volume":"17","author":"Rea","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.002_bib3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","article-title":"Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.002_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ki.1991.43","article-title":"Diuretics","volume":"39","author":"Rose","year":"1991","journal-title":"Kidney Int"},{"issue":"14","key":"10.1016\/j.mayocp.2015.05.002_bib5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jacc.2012.12.043","article-title":"Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?","volume":"61","author":"Bikdeli","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1017\/S0022215100105523","article-title":"Ototoxicity of ethacrynic acid (a persistent clinical problem)","volume":"102","author":"Rybak","year":"1988","journal-title":"J\u00a0Laryngol Otol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archinte.163.1.116","article-title":"Ethacrynic acid and the sulfa-sensitive patient","volume":"163","author":"Wall","year":"2003","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.002_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-102-3-314","article-title":"Furosemide absorption altered in decompensated congestive heart failure","volume":"102","author":"Vasco","year":"1985","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2165\/00003088-198712060-00004","article-title":"Bioavailability of bumetanide in grossly oedematous patients","volume":"12","author":"Bailie","year":"1987","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.002_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/j.1552-4604.1998.tb04810.x","article-title":"Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure","volume":"38","author":"Bleske","year":"1998","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.mayocp.2015.05.002_bib12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/hrt.2005.079764","article-title":"Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in\u00a0patients with congestive heart failure","volume":"92","author":"Kasama","year":"2006","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.002_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(91)90812-5","article-title":"Anti-aldosteronergic effect of torasemide","volume":"205","author":"Uchida","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.05.002_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study","volume":"4","author":"Cosin","year":"2002","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.002_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0011-393X(97)80026-4","article-title":"Torasemide versus furosemide in patients with congestive heart failure: a double-masked, randomized study","volume":"58","author":"Ferrara","year":"1997","journal-title":"Curr Ther Res"},{"issue":"11","key":"10.1016\/j.mayocp.2015.05.002_bib16","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"Lopez","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.mayocp.2015.05.002_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","article-title":"Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV: efficacy and quality of life","volume":"5","author":"Muller","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.mayocp.2015.05.002_bib19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1253\/circj.CJ-11-1500","article-title":"Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure","volume":"76","author":"Masuyama","year":"2012","journal-title":"Circ J"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.002_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.002_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.mayocp.2015.05.002_bib22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-114-10-886","article-title":"The physiologic basis of diuretic synergism: its role in treating diuretic resistance","volume":"114","author":"Ellison","year":"1991","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000082314","article-title":"Long-term adaptation of renal ion transporters to chronic diuretic treatment","volume":"24","author":"Kim","year":"2004","journal-title":"Am J Nephrol"},{"issue":"8640","key":"10.1016\/j.mayocp.2015.05.002_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(89)92243-5","article-title":"Oral metolazone plus furosemide for home therapy in patients with refractory heart failure","volume":"333","author":"Aravot","year":"1989","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.002_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/hrt.71.2.146","article-title":"Combination diuretic treatment in severe heart failure: a randomised controlled trial","volume":"71","author":"Channer","year":"1994","journal-title":"Br Heart J"},{"issue":"19","key":"10.1016\/j.mayocp.2015.05.002_bib26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.mayocp.2015.05.002_bib27","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mayocp.2015.05.002_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.002_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCHEARTFAILURE.109.906909","article-title":"Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction","volume":"3","author":"Udelson","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.002_bib31","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor","volume":"71","author":"van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","article-title":"Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure","volume":"25","author":"Ferreira","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.002_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/17482940701210179","article-title":"Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial","volume":"9","author":"Rossi","year":"2007","journal-title":"Acute Card Care"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cardfail.2013.04.001","article-title":"Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan","volume":"19","author":"Hauptman","year":"2013","journal-title":"J\u00a0Card Fail"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.002_bib35","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2005.11.071","article-title":"Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients","volume":"47","author":"Abraham","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.002_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1752-8062.2010.00217.x","article-title":"Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III\/IV cardiac patient evaluation (THE BALANCE) study","volume":"3","author":"Abraham","year":"2010","journal-title":"Clin Transl Sci"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.002_bib37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cardfail.2008.06.003","article-title":"Efficacy and safety of the vasopressin V1A\/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study","volume":"14","author":"Goldsmith","year":"2008","journal-title":"J\u00a0Card Fail"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib38","doi-asserted-by":"crossref","first-page":"59S","DOI":"10.1093\/ajh\/3.6.59S","article-title":"Dopamine-1 and dopamine-2 mechanisms in the control of renal function","volume":"3","author":"Carey","year":"1990","journal-title":"Am J Hypertens"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2015.05.002_bib39","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1291\/hypres.18.SupplementI_S137","article-title":"Different mechanisms of renal Na-KATPase regulation by dopamine in the proximal and distal nephron","volume":"18","author":"Satoh","year":"1995","journal-title":"Hypertens Res"},{"issue":"7","key":"10.1016\/j.mayocp.2015.05.002_bib40","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00134-002-1346-y","article-title":"Low-dose dopamine: a systematic review","volume":"28","author":"Marik","year":"2002","journal-title":"Intens Care Med"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.002_bib41","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00003246-200108000-00005","article-title":"Use of dopamine in acute renal failure: a meta-analysis","volume":"29","author":"Kellum","year":"2001","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.mayocp.2015.05.002_bib42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7326\/0003-4819-142-7-200504050-00010","article-title":"Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death","volume":"142","author":"Friedrich","year":"2005","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2015.05.002_bib43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/clc.4960200709","article-title":"The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: does it protect renal function?","volume":"20","author":"Varriale","year":"1997","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.002_bib44","first-page":"227","article-title":"Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days","volume":"52","author":"Aziz","year":"2011","journal-title":"Hellenic J Cardiol"},{"issue":"12","key":"10.1016\/j.mayocp.2015.05.002_bib45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cardfail.2010.07.246","article-title":"Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J\u00a0Card Fail"},{"issue":"23","key":"10.1016\/j.mayocp.2015.05.002_bib46","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.002_bib47","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCHEARTFAILURE.113.000347","article-title":"Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial","volume":"6","author":"Chen","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.002_bib48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00000542-200002000-00013","article-title":"Pharmacokinetics of dopamine in healthy male subjects","volume":"92","author":"MacGregor","year":"2000","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.002_bib49","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/sj.ki.5000310","article-title":"\u201cLow-dose\u201d dopamine worsens renal perfusion in patients with acute renal failure","volume":"69","author":"Lauschke","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.002_bib50","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/01.CCM.0000124871.58281.D1","article-title":"Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure","volume":"32","author":"Ungar","year":"2004","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.mayocp.2015.05.002_bib51","first-page":"1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated heart failure: a randomized controlled trial","volume":"287","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2015.05.002_bib52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM200007273430403","article-title":"Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure","volume":"343","author":"Colucci","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib53","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1067\/mhj.2002.125620","article-title":"Effect of nesiritide (b-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study","volume":"144","author":"Burger","year":"2002","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.mayocp.2015.05.002_bib54","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.mayocp.2015.05.002_bib55","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","article-title":"Short-term risk of deathafter treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials","volume":"293","author":"Sackner-Bernstein","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCHEARTFAILURE.108.767483","article-title":"Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial","volume":"1","author":"Yancy","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.mayocp.2015.05.002_bib58","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jacc.2013.04.073","article-title":"Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure)","volume":"62","author":"Gottlieb","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJMe1103116","article-title":"The lost decade of nesiritide","volume":"365","author":"Topol","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.002_bib60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cardfail.2006.02.012","article-title":"Large volume ultrafiltration for acute decompensated heart failure using standard peripheral intravenous catheters","volume":"12","author":"Dahle","year":"2006","journal-title":"J\u00a0Card Fail"},{"issue":"11","key":"10.1016\/j.mayocp.2015.05.002_bib61","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2005.05.098","article-title":"Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial","volume":"46","author":"Bart","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cardfail.2008.02.003","article-title":"Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration","volume":"14","author":"Jaski","year":"2008","journal-title":"J\u00a0Card Fail"},{"issue":"11","key":"10.1016\/j.mayocp.2015.05.002_bib63","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2005.05.099","article-title":"Early ultrafiltration in patients with decompensated heart failure and diuretic resistance","volume":"46","author":"Costanzo","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.002_bib64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0735-1097(93)90685-T","article-title":"Isolated ultrafiltration in moderate congestive heart failure","volume":"21","author":"Agostoni","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.002_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0002-9343(94)90142-2","article-title":"Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result","volume":"96","author":"Agostoni","year":"1994","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.05.002_bib66","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardfail.2007.09.007","article-title":"A\u00a0randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure","volume":"14","author":"Rogers","year":"2008","journal-title":"J\u00a0Card Fail"},{"issue":"24","key":"10.1016\/j.mayocp.2015.05.002_bib68","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2015.05.002_bib69","unstructured":"ClinicalTrials.gov. Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment (AVOID-HF). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01474200. Accessed May 23, 2015."},{"issue":"4, pt 1","key":"10.1016\/j.mayocp.2015.05.002_bib70","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/01.CIR.88.4.1620","article-title":"Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure","volume":"88","author":"Volpe","year":"1993","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.002_bib71","doi-asserted-by":"crossref","first-page":"R1294","DOI":"10.1152\/ajpregu.00738.2005","article-title":"Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure","volume":"290","author":"Damgaard","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jemermed.2012.02.081","article-title":"Eating a larger number of high-salt foods is not associated with short-term risk of acute decompensation in patients with chronic heart failure","volume":"44","author":"Borke","year":"2013","journal-title":"J\u00a0Emerg Med"},{"issue":"14","key":"10.1016\/j.mayocp.2015.05.002_bib73","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.107.690768","article-title":"Patterns of weight change preceding hospitalization for heart failure","volume":"116","author":"Chaudhry","year":"2007","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.mayocp.2015.05.002_bib74","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","article-title":"Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures","volume":"118","author":"Zile","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.002_bib75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/CS20070193","article-title":"Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?","volume":"114","author":"Paterna","year":"2008","journal-title":"Clin Sci"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.amjcard.2008.08.043","article-title":"Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure","volume":"103","author":"Paterna","year":"2009","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.002_bib77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3945\/ajcn.110.000174","article-title":"A\u00a0high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study","volume":"93","author":"Arcand","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.mayocp.2015.05.002_bib78","first-page":"1058","article-title":"Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial","volume":"173","author":"Aliti","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mayocp.2015.05.002_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects","volume":"145","author":"Licata","year":"2003","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.mayocp.2015.05.002_bib80","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ajh.2011.115","article-title":"Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review)","volume":"24","author":"Taylor","year":"2011","journal-title":"Am J Hypertens"},{"issue":"16","key":"10.1016\/j.mayocp.2015.05.002_bib81","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2015.05.002_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ajh.2011.187","article-title":"Dietary sodium reduction in heart failure: a challenge to the Cochrane Review","volume":"25","author":"Arcand","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mayocp.2015.05.002_bib83","unstructured":"Centers for Medicaid and Medicare Services. Readmissions Reduction Program. http:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/AcuteInpatientPPS\/Readmissions-Reduction-Program.html. Last updated August 4,\u00a02014. Accessed May 23, 2015."},{"issue":"4","key":"10.1016\/j.mayocp.2015.05.002_bib84","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0002-8703(03)00393-4","article-title":"Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial","volume":"146","author":"Goldberg","year":"2003","journal-title":"Am Heart J"},{"issue":"24","key":"10.1016\/j.mayocp.2015.05.002_bib85","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMoa1010029","article-title":"Telemonitoring in patients with heart failure","volume":"363","author":"Chaudhry","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.mayocp.2015.05.002_bib86","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.111.018473","article-title":"Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study","volume":"123","author":"Koehler","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.002_bib87","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/oxfordjournals.eurheartj.a015464","article-title":"The technique of impedance cardiography","volume":"18","author":"Woltjer","year":"1997","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.mayocp.2015.05.002_bib88","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.jacc.2005.12.071","article-title":"Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure","volume":"47","author":"Packer","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2015.05.002_bib89","unstructured":"ClinicalTrials.gov. report-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing. https:\/\/clinicaltrials.gov\/show\/NCT00409916. Accessed May 23, 2015."},{"issue":"18","key":"10.1016\/j.mayocp.2015.05.002_bib90","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/archinte.162.18.2084","article-title":"Evaluation of a noninvasive system for determining left ventricular filling pressure","volume":"162","author":"Sharma","year":"2002","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.002_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2011.04.014","article-title":"Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial","volume":"17","author":"Sharma","year":"2011","journal-title":"J\u00a0Card Fail"},{"issue":"11","key":"10.1016\/j.mayocp.2015.05.002_bib92","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2007.10.061","article-title":"Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study","volume":"51","author":"Bourge","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.05.002_bib93","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1751-7133.2011.00247.x","article-title":"Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of the Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (REDUCEhf) trial","volume":"17","author":"Adamson","year":"2011","journal-title":"Congest Heart Fail"},{"issue":"2","key":"10.1016\/j.mayocp.2015.05.002_bib94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1751-7133.2011.00220.x","article-title":"Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST)","volume":"17","author":"Abraham","year":"2011","journal-title":"Congest Heart Fail"},{"issue":"16","key":"10.1016\/j.mayocp.2015.05.002_bib95","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/CIRCULATIONAHA.111.043042","article-title":"Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure","volume":"124","author":"van Veldhuisen","year":"2011","journal-title":"Circulation"},{"issue":"9766","key":"10.1016\/j.mayocp.2015.05.002_bib96","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2015.05.002_bib97","unstructured":"ClinicalTrials.gov. Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy (LAPTOP-HF). http:\/\/clinicaltrials.gov\/show\/NCT01121107. Accessed May 23, 2015."},{"issue":"9","key":"10.1016\/j.mayocp.2015.05.002_bib98","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCULATIONAHA.108.800490","article-title":"Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure","volume":"121","author":"Ritzema","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2015.05.002_bib99","unstructured":"ClinicalTrials.gov. Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (PAPIRUS III). https:\/\/clinicaltrials.gov\/show\/NCT00893828. Accessed May 23, 2015."}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615003511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615003511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T21:21:30Z","timestamp":1537478490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619615003511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":99,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0025619615003511"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.05.002","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}